Literature DB >> 448139

Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret.

S C Suffin, G A Prince, K B Muck, D D Porter.   

Abstract

Infant ferrets can be protected from respiratory syncytical virus challenge at 3 days of age by gestational infection of their mothers. Ferrets acquire their immunity to respiratory syncytial virus postpartum via immunizing products of lactation. The level of protection against viral replication correlates with the maternal serum neutralizing titer or a concomitant factor. Passive administration of adult ferret serum with a neutralizing titer of 1:1024 or greater, either i.p. or orally does not confer immunity. A nonantibody-mediated protective mechanism appears to play an important role in protecting the infant ferret from respiratory syncytial virus replication. Our findings allow the testing of the efficacy of future human vaccines before human clinical trial.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448139

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines.

Authors:  C Sweet; R A Bird; K Jakeman; D M Coates; H Smith
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

Review 2.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

3.  Mechanisms of immunity to respiratory syncytial virus in cotton rats.

Authors:  G A Prince; R L Horswood; E Camargo; D Koenig; R M Chanock
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

4.  Role of maternal immunity in the protection of newborn ferrets against infection with a virulent influenza virus.

Authors:  R H Husseini; C Sweet; H Overton; H Smith
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

Review 5.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  The susceptibility of breast-fed and cow's milk formula-fed infant guinea pigs to upper respiratory tract infection with influenza virus.

Authors:  H M Ali; R Scott; G L Toms
Journal:  Br J Exp Pathol       Date:  1988-08

Review 7.  Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery.

Authors:  M G Ottolini; V G Hemming
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 8.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

9.  Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.

Authors:  T G Kimman; F Westenbrink; B E Schreuder; P J Straver
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

Review 10.  Viral infection of the lung: host response and sequelae.

Authors:  Jae-Kwang Yoo; Taeg S Kim; Matthew M Hufford; Thomas J Braciale
Journal:  J Allergy Clin Immunol       Date:  2013-08-01       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.